| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fructose 1,6-bisphosphate 1-phosphatase activity | 5.24e-05 | 2 | 145 | 2 | GO:0042132 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 5.24e-05 | 2 | 145 | 2 | GO:0005093 | |
| GeneOntologyCellularComponent | vesicle membrane | MGAM RHOD SYN3 RIPK1 HBEGF APC GRIA3 VPS36 ITGA2B HMOX2 RAB14 CLCN3 TM9SF2 PTPRS SLC18A2 LRP1 GALNTL5 RIPOR1 KIR3DL1 SORL1 EPHA8 | 2.20e-04 | 1325 | 141 | 21 | GO:0012506 |
| GeneOntologyCellularComponent | somatodendritic compartment | SLC25A27 DPP6 LHFPL4 MYO10 APC GRIA3 GJC2 CLSTN2 GDI1 KCNA4 PTPRS SLC18A2 RPTOR LRP1 USH2A DYNC1H1 CNN3 EPHA3 SORL1 EPHA8 | 2.21e-04 | 1228 | 141 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MGAM RHOD SYN3 RIPK1 HBEGF APC GRIA3 VPS36 ITGA2B HMOX2 RAB14 CLCN3 TM9SF2 PTPRS SLC18A2 LRP1 GALNTL5 KIR3DL1 SORL1 EPHA8 | 4.94e-04 | 1307 | 141 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | neuronal cell body | SLC25A27 DPP6 MYO10 APC GRIA3 GJC2 GDI1 PTPRS SLC18A2 RPTOR LRP1 USH2A DYNC1H1 CNN3 SORL1 | 5.27e-04 | 835 | 141 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | focal adhesion | 7.01e-04 | 431 | 141 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 8.64e-04 | 443 | 141 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | anchoring junction | TNC APC GJC2 FBP2 ITGA2B AQP7P3 GDI2 FOCAD JAK1 FAT2 LRP1 ADAM17 TNS1 CDH6 CNN1 CNN3 | 9.15e-04 | 976 | 141 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | axon | EXOC6 FSCN3 SPTA1 APC GRIA3 GJC2 GDI1 CNTN6 KCNA4 CLCN3 PTPRS SLC18A2 LRP1 USH2A DYNC1H1 | 1.02e-03 | 891 | 141 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 1.37e-03 | 179 | 141 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 1.37e-03 | 179 | 141 | 6 | GO:0030672 | |
| GeneOntologyCellularComponent | postsynapse | LHFPL4 SYN3 APC GRIA3 CLSTN2 ADD2 KCNA4 CLCN3 PTPRS SLC18A2 LRP1 FGF7 USP48 KCNT1 CNN3 RPL18A | 1.42e-03 | 1018 | 141 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | cell body | SLC25A27 DPP6 MYO10 APC GRIA3 GJC2 GDI1 PTPRS SLC18A2 RPTOR LRP1 USH2A DYNC1H1 CNN3 SORL1 | 1.54e-03 | 929 | 141 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.74e-03 | 405 | 141 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | secretory vesicle | MGAM SYN3 APC IDH1 POMT1 ITGA2B HMOX2 ASTL RAB14 GDI2 FRK CLCN3 PTPRS SLC18A2 AGL LRP1 DYNC1H1 IQUB | 1.83e-03 | 1246 | 141 | 18 | GO:0099503 |
| Domain | FN3 | 1.29e-05 | 185 | 143 | 9 | SM00060 | |
| Domain | DHC_N1 | 2.39e-05 | 8 | 143 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.39e-05 | 8 | 143 | 3 | IPR013594 | |
| Domain | FN3_dom | 3.38e-05 | 209 | 143 | 9 | IPR003961 | |
| Domain | fn3 | 3.55e-05 | 162 | 143 | 8 | PF00041 | |
| Domain | Fructose_bisphosphatase_AS | 5.82e-05 | 2 | 143 | 2 | IPR020548 | |
| Domain | RabGDI | 5.82e-05 | 2 | 143 | 2 | IPR000806 | |
| Domain | FBPtase | 5.82e-05 | 2 | 143 | 2 | IPR028343 | |
| Domain | FBPase_N | 5.82e-05 | 2 | 143 | 2 | IPR033391 | |
| Domain | FBPase | 5.82e-05 | 2 | 143 | 2 | PF00316 | |
| Domain | FBPASE | 5.82e-05 | 2 | 143 | 2 | PS00124 | |
| Domain | FN3 | 1.50e-04 | 199 | 143 | 8 | PS50853 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.50e-04 | 14 | 143 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.50e-04 | 14 | 143 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.50e-04 | 14 | 143 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.50e-04 | 14 | 143 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.50e-04 | 14 | 143 | 3 | IPR011704 | |
| Domain | MT | 1.50e-04 | 14 | 143 | 3 | PF12777 | |
| Domain | AAA_8 | 1.50e-04 | 14 | 143 | 3 | PF12780 | |
| Domain | AAA_5 | 1.50e-04 | 14 | 143 | 3 | PF07728 | |
| Domain | USP_CS | 1.51e-04 | 66 | 143 | 5 | IPR018200 | |
| Domain | FBPase_class-1 | 1.74e-04 | 3 | 143 | 2 | IPR000146 | |
| Domain | K_chnl_volt-dep_ERG | 1.74e-04 | 3 | 143 | 2 | IPR003967 | |
| Domain | EGF-like_CS | 1.85e-04 | 261 | 143 | 9 | IPR013032 | |
| Domain | DHC_fam | 1.87e-04 | 15 | 143 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.87e-04 | 15 | 143 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.87e-04 | 15 | 143 | 3 | IPR004273 | |
| Domain | USP_1 | 1.99e-04 | 70 | 143 | 5 | PS00972 | |
| Domain | EGF_2 | 2.07e-04 | 265 | 143 | 9 | PS01186 | |
| Domain | UCH | 2.13e-04 | 71 | 143 | 5 | PF00443 | |
| Domain | USP_2 | 2.13e-04 | 71 | 143 | 5 | PS00973 | |
| Domain | USP_3 | 2.27e-04 | 72 | 143 | 5 | PS50235 | |
| Domain | USP_dom | 2.27e-04 | 72 | 143 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.27e-04 | 72 | 143 | 5 | IPR001394 | |
| Domain | LamGL | 3.46e-04 | 4 | 143 | 2 | SM00560 | |
| Domain | LamG-like | 3.46e-04 | 4 | 143 | 2 | IPR006558 | |
| Domain | GDI | 3.46e-04 | 4 | 143 | 2 | PF00996 | |
| Domain | Calponin/LIMCH1 | 3.46e-04 | 4 | 143 | 2 | IPR001997 | |
| Domain | GDP_dissociation_inhibitor | 3.46e-04 | 4 | 143 | 2 | IPR018203 | |
| Domain | - | 3.94e-04 | 81 | 143 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 3.94e-04 | 81 | 143 | 5 | IPR024079 | |
| Domain | Calponin_repeat | 8.56e-04 | 6 | 143 | 2 | IPR000557 | |
| Domain | Calponin | 8.56e-04 | 6 | 143 | 2 | PF00402 | |
| Domain | CALPONIN_1 | 8.56e-04 | 6 | 143 | 2 | PS01052 | |
| Domain | CALPONIN_2 | 8.56e-04 | 6 | 143 | 2 | PS51122 | |
| Domain | ZINC_PROTEASE | 9.41e-04 | 98 | 143 | 5 | PS00142 | |
| Domain | DUSP | 1.19e-03 | 7 | 143 | 2 | PS51283 | |
| Domain | - | 1.19e-03 | 7 | 143 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 1.19e-03 | 7 | 143 | 2 | IPR006615 | |
| Domain | EGF | 2.25e-03 | 235 | 143 | 7 | SM00181 | |
| Domain | EGF_3 | 2.25e-03 | 235 | 143 | 7 | PS50026 | |
| Domain | PAS_9 | 2.52e-03 | 10 | 143 | 2 | PF13426 | |
| Domain | Cytokine_IL1-like | 2.61e-03 | 36 | 143 | 3 | IPR008996 | |
| Domain | SM22_calponin | 3.06e-03 | 11 | 143 | 2 | IPR003096 | |
| Domain | EGF-like_dom | 3.10e-03 | 249 | 143 | 7 | IPR000742 | |
| Domain | Pkinase_Tyr | 3.16e-03 | 129 | 143 | 5 | PF07714 | |
| Domain | - | 3.28e-03 | 39 | 143 | 3 | 2.120.10.30 | |
| Domain | EGF_1 | 3.53e-03 | 255 | 143 | 7 | PS00022 | |
| Domain | Proteasome_bsu_CS | 3.65e-03 | 12 | 143 | 2 | IPR016050 | |
| Domain | Mit_uncoupling | 3.65e-03 | 12 | 143 | 2 | IPR002030 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.21e-03 | 138 | 143 | 5 | IPR001245 | |
| Domain | 6-hairpin_glycosidase-like | 4.30e-03 | 13 | 143 | 2 | IPR008928 | |
| Domain | Tyr_kinase_cat_dom | 4.67e-03 | 88 | 143 | 4 | IPR020635 | |
| Domain | TyrKc | 4.67e-03 | 88 | 143 | 4 | SM00219 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.99e-03 | 14 | 143 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.99e-03 | 14 | 143 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.99e-03 | 14 | 143 | 2 | IPR001426 | |
| Domain | EphA2_TM | 4.99e-03 | 14 | 143 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.99e-03 | 14 | 143 | 2 | IPR001090 | |
| Domain | Eph_TM | 4.99e-03 | 14 | 143 | 2 | IPR027936 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.99e-03 | 14 | 143 | 2 | IPR003938 | |
| Domain | EPH_lbd | 4.99e-03 | 14 | 143 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 4.99e-03 | 14 | 143 | 2 | PF01404 | |
| Domain | Ldl_recept_b | 4.99e-03 | 14 | 143 | 2 | PF00058 | |
| Domain | LDLRB | 4.99e-03 | 14 | 143 | 2 | PS51120 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.99e-03 | 14 | 143 | 2 | IPR016257 | |
| Domain | EPH_LBD | 4.99e-03 | 14 | 143 | 2 | PS51550 | |
| Domain | - | PAPPA2 SDK2 TNC ICAM3 CNTN6 PTPRS KIR3DL1 KIR3DS1 USH2A EPHA3 SORL1 EPHA8 | 5.01e-03 | 663 | 143 | 12 | 2.60.40.10 |
| Domain | 6-blade_b-propeller_TolB-like | 5.24e-03 | 46 | 143 | 3 | IPR011042 | |
| Domain | ER_TARGET | 5.57e-03 | 47 | 143 | 3 | PS00014 | |
| Domain | LY | 5.73e-03 | 15 | 143 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.73e-03 | 15 | 143 | 2 | IPR000033 | |
| Domain | - | 6.12e-03 | 95 | 143 | 4 | 2.60.120.200 | |
| Domain | FKBP_PPIASE | 6.51e-03 | 16 | 143 | 2 | PS50059 | |
| Domain | FKBP_C | 6.51e-03 | 16 | 143 | 2 | PF00254 | |
| Domain | PROTEIN_KINASE_TYR | 6.59e-03 | 97 | 143 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.59e-03 | 97 | 143 | 4 | IPR008266 | |
| Domain | PPIase_FKBP | 7.34e-03 | 17 | 143 | 2 | IPR023566 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.20e-07 | 91 | 146 | 7 | 28558017 | |
| Pubmed | 5.00e-07 | 164 | 146 | 8 | 32409323 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 2.44e-06 | 272 | 146 | 9 | 18187620 | |
| Pubmed | DPP6 SYN3 TNC SPTA1 FKBP9 APC GJC2 RAB14 GDI1 GDI2 LANCL2 HNRNPF ADD2 GDA PTPRS RPTOR DDX3Y TNS1 DYNC1H1 RPL18A | 2.47e-06 | 1431 | 146 | 20 | 37142655 | |
| Pubmed | 2.79e-06 | 93 | 146 | 6 | 27215380 | ||
| Pubmed | GTPBP6 TTC28 USP11 APC ZNF214 HMOX2 USP9Y GDI1 ADARB1 USP16 HNRNPF ZNF512B FOCAD JAK1 HPF1 LRP1 ZNF76 DYNC1H1 | 7.97e-06 | 1285 | 146 | 18 | 35914814 | |
| Pubmed | 9.07e-06 | 114 | 146 | 6 | 28245920 | ||
| Pubmed | PSMA4 ITGA2B VWDE HNRNPF HEPH STT3A PTPRS P3H1 LRP1 DDX3Y ADAM17 SORL1 | 1.17e-05 | 613 | 146 | 12 | 22268729 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FKBP10 GNE USP11 PSMA4 FKBP9 PSMB8 VPS36 IDH1 GDI1 GDI2 HNRNPF GDA P3H1 AGL RIPOR1 USP48 NUP160 DYNC1H1 RPL18A | 1.18e-05 | 1455 | 146 | 19 | 22863883 |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20610799 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28306378 | ||
| Pubmed | No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis. | 1.75e-05 | 2 | 146 | 2 | 19874556 | |
| Pubmed | Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease. | 1.75e-05 | 2 | 146 | 2 | 27708262 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24523901 | ||
| Pubmed | Molecular cloning and gene mapping of human basic and acidic calponins. | 1.75e-05 | 2 | 146 | 2 | 8526917 | |
| Pubmed | LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage. | 1.75e-05 | 2 | 146 | 2 | 23064555 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 18331531 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 16805919 | ||
| Pubmed | Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver. | 1.75e-05 | 2 | 146 | 2 | 18780768 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27213585 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30610007 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19211742 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 38217953 | ||
| Pubmed | Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. | 1.75e-05 | 2 | 146 | 2 | 35192601 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 37647275 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20131260 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 36997603 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25112829 | ||
| Pubmed | Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. | 1.75e-05 | 2 | 146 | 2 | 17694054 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 7585614 | ||
| Pubmed | Contribution of functional KIR3DL1 to ankylosing spondylitis. | 1.75e-05 | 2 | 146 | 2 | 20818412 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23524032 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10773464 | ||
| Pubmed | Various fructose-1,6-bisphosphatase mRNAs in mouse brain, liver, kidney and heart. | 1.75e-05 | 2 | 146 | 2 | 9106734 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28881611 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30365992 | ||
| Pubmed | Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. | 1.75e-05 | 2 | 146 | 2 | 17182560 | |
| Pubmed | Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. | 1.75e-05 | 2 | 146 | 2 | 28169277 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19008943 | ||
| Pubmed | The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity. | 1.75e-05 | 2 | 146 | 2 | 22517657 | |
| Pubmed | Characterization of the mouse liver fructose-1,6-bisphosphatase gene. | 1.75e-05 | 2 | 146 | 2 | 11250076 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 31461648 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19386717 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28942035 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20230527 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11098931 | ||
| Pubmed | Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. | 1.75e-05 | 2 | 146 | 2 | 19411600 | |
| Pubmed | Fructose bisphosphatase isozymes of the mouse. I. Inheritance. | 1.75e-05 | 2 | 146 | 2 | 2996484 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15303969 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20671934 | ||
| Pubmed | 2.55e-05 | 14 | 146 | 3 | 9373155 | ||
| Pubmed | 2.85e-05 | 370 | 146 | 9 | 15164053 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 3.18e-05 | 15 | 146 | 3 | 9827704 | |
| Pubmed | RIPK1 USP11 HMOX2 STT3A FARS2 P3H1 RPTOR LRP1 DDX3Y ILVBL DYNC1H1 EPHA8 | 3.51e-05 | 686 | 146 | 12 | 28380382 | |
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 4.72e-05 | 17 | 146 | 3 | 23287719 | |
| Pubmed | RIPK1 TTC28 PSMA4 APC LANCL2 HNRNPF ADD2 STT3A EFR3B DYNC1H1 CNN3 EPHA3 | 4.75e-05 | 708 | 146 | 12 | 39231216 | |
| Pubmed | Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia. | 5.24e-05 | 3 | 146 | 2 | 17066476 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24474687 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 26182433 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24059286 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 26240314 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24423473 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 20056793 | ||
| Pubmed | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | 5.24e-05 | 3 | 146 | 2 | 11859120 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 38237079 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28799085 | ||
| Pubmed | Associations of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis. | 5.24e-05 | 3 | 146 | 2 | 11066089 | |
| Pubmed | HERG K(+) currents in human prolactin-secreting adenoma cells. | 5.24e-05 | 3 | 146 | 2 | 12634931 | |
| Pubmed | Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. | 5.24e-05 | 3 | 146 | 2 | 17301953 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 27820599 | ||
| Pubmed | DPP6 regulation of dendritic morphogenesis impacts hippocampal synaptic development. | 5.24e-05 | 3 | 146 | 2 | 23912628 | |
| Pubmed | Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. | 5.24e-05 | 3 | 146 | 2 | 12826375 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 14643686 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 12033495 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28543390 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 7543319 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 27476853 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 19859704 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 22524567 | ||
| Pubmed | Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas. | 5.24e-05 | 3 | 146 | 2 | 20702649 | |
| Pubmed | Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome. | 5.24e-05 | 3 | 146 | 2 | 35818223 | |
| Pubmed | The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis. | 5.24e-05 | 3 | 146 | 2 | 34294846 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 7513052 | ||
| Pubmed | Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. | 5.24e-05 | 3 | 146 | 2 | 19019897 | |
| Pubmed | Tyrosine phosphorylation of calponins. Inhibition of the interaction with F-actin. | 5.24e-05 | 3 | 146 | 2 | 15206927 | |
| Pubmed | 5.65e-05 | 18 | 146 | 3 | 19455133 | ||
| Pubmed | 7.36e-05 | 325 | 146 | 8 | 36168628 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP18 TTC28 MYO10 USP11 PSMA4 APC HMOX2 USP16 LANCL2 FARS2 P3H1 LRP1 USP48 NUP160 | 9.13e-05 | 1005 | 146 | 14 | 19615732 |
| Pubmed | 9.24e-05 | 56 | 146 | 4 | 27103069 | ||
| Pubmed | 9.70e-05 | 251 | 146 | 7 | 27507650 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 29694894 | ||
| Pubmed | Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. | 1.04e-04 | 4 | 146 | 2 | 12773386 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 30022999 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 37169313 | ||
| Pubmed | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. | 1.04e-04 | 4 | 146 | 2 | 27455421 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 11994670 | ||
| Pubmed | Associations between polymorphisms in the mitochondrial uncoupling proteins (UCPs) with T2DM. | 1.04e-04 | 4 | 146 | 2 | 18755175 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 15187129 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 21386996 | ||
| Pubmed | ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling. | 1.04e-04 | 4 | 146 | 2 | 29472497 | |
| Cytoband | 9q22.3 | 6.79e-06 | 12 | 146 | 3 | 9q22.3 | |
| GeneFamily | Fibronectin type III domain containing | 4.25e-06 | 160 | 105 | 8 | 555 | |
| GeneFamily | Ubiquitin specific peptidases | 1.81e-05 | 56 | 105 | 5 | 366 | |
| GeneFamily | Fructose-1,6-bisphosphatases | 3.34e-05 | 2 | 105 | 2 | 1075 | |
| GeneFamily | Potassium voltage-gated channels | 1.61e-03 | 40 | 105 | 3 | 274 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.90e-03 | 14 | 105 | 2 | 1095 | |
| GeneFamily | Dyneins, axonemal | 4.29e-03 | 17 | 105 | 2 | 536 | |
| GeneFamily | Cadherin related | 4.29e-03 | 17 | 105 | 2 | 24 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 4.81e-03 | 18 | 105 | 2 | 620 | |
| GeneFamily | FKBP prolyl isomerases | 4.81e-03 | 18 | 105 | 2 | 910 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 TNC MYO10 USP11 FKBP9 GRIA3 ADAMTS5 ANGPTL1 PGM3 CNTN6 FRK PPP3CC P3H1 LRP1 DDX3Y TNS1 EPHA3 | 1.84e-05 | 768 | 144 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 USP11 FKBP9 GRIA3 HMGCS1 ADAMTS5 IDH1 ANGPTL1 HEPH PGM3 CNTN6 FRK P3H1 LRP1 DDX3Y CNN1 EPHA3 | 2.00e-05 | 773 | 144 | 17 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | FKBP10 TNC ECM2 FKBP9 ADAMTS5 ANGPTL1 RNASE4 LRP1 FGF7 MMP19 TNS1 EPHA3 | 4.45e-05 | 437 | 144 | 12 | GSM777046_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.21e-05 | 310 | 144 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | SDK2 TNC FKBP9 GRIA3 ADAMTS5 PCDH20 CNTN6 PPP3CC PTPRS SLC18A2 KCNH2 P3H1 LRP1 CDH6 KCNT1 CNN1 CNN3 | 7.35e-05 | 858 | 144 | 17 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.02e-04 | 336 | 144 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FKBP10 ZNF536 TNC GRIA3 ADAMTS5 ANGPTL1 PTPRS LRP1 FGF7 CDH6 CNN1 EPHA3 | 1.47e-12 | 189 | 145 | 12 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-10 | 191 | 145 | 10 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | FKBP10 ZNF536 TNC ADAMTS5 ANGPTL1 PTPRS FGF7 CDH6 CNN1 EPHA3 | 7.53e-10 | 191 | 145 | 10 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.42e-09 | 183 | 145 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-08 | 189 | 145 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-08 | 197 | 145 | 9 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.87e-08 | 198 | 145 | 9 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | distal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.87e-08 | 198 | 145 | 9 | fbfac1d10e4224990a094cc84b74bbc206881423 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-08 | 199 | 145 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.95e-08 | 199 | 145 | 9 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 199 | 145 | 9 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 199 | 145 | 9 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-07 | 179 | 145 | 8 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.96e-07 | 188 | 145 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 192 | 145 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-07 | 194 | 145 | 8 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.49e-07 | 194 | 145 | 8 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-07 | 194 | 145 | 8 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.69e-07 | 196 | 145 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.79e-07 | 197 | 145 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-07 | 198 | 145 | 8 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.02e-07 | 199 | 145 | 8 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 3.02e-07 | 199 | 145 | 8 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.14e-07 | 200 | 145 | 8 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.14e-07 | 200 | 145 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.14e-07 | 200 | 145 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 172 | 145 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.76e-06 | 175 | 145 | 7 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-06 | 175 | 145 | 7 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.76e-06 | 175 | 145 | 7 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-06 | 179 | 145 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 181 | 145 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 181 | 145 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 182 | 145 | 7 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 2.36e-06 | 183 | 145 | 7 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 184 | 145 | 7 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 184 | 145 | 7 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-06 | 184 | 145 | 7 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 185 | 145 | 7 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 185 | 145 | 7 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-06 | 185 | 145 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.63e-06 | 186 | 145 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.63e-06 | 186 | 145 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.73e-06 | 187 | 145 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 188 | 145 | 7 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 188 | 145 | 7 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 189 | 145 | 7 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 189 | 145 | 7 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 189 | 145 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 189 | 145 | 7 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 189 | 145 | 7 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 3.00e-06 | 122 | 145 | 6 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 190 | 145 | 7 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 190 | 145 | 7 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-06 | 191 | 145 | 7 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-06 | 192 | 145 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-06 | 192 | 145 | 7 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 193 | 145 | 7 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 193 | 145 | 7 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-06 | 193 | 145 | 7 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-06 | 193 | 145 | 7 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.36e-06 | 193 | 145 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 193 | 145 | 7 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 193 | 145 | 7 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-06 | 193 | 145 | 7 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 194 | 145 | 7 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 194 | 145 | 7 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 194 | 145 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 194 | 145 | 7 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 195 | 145 | 7 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.59e-06 | 195 | 145 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-06 | 195 | 145 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.59e-06 | 195 | 145 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.72e-06 | 196 | 145 | 7 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.72e-06 | 196 | 145 | 7 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 3.72e-06 | 196 | 145 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 196 | 145 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 196 | 145 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 197 | 145 | 7 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.84e-06 | 197 | 145 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.84e-06 | 197 | 145 | 7 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.84e-06 | 197 | 145 | 7 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | distal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-06 | 198 | 145 | 7 | dc93886439a378a0c71e99acb8081bfb6b6d467b | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.97e-06 | 198 | 145 | 7 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 198 | 145 | 7 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 199 | 145 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | a538da095ba996ee96e263442cf5b6ba9178f3d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 199 | 145 | 7 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.11e-06 | 199 | 145 | 7 | cb3c04b91c8e8080137823b11c76ca0a2adda52d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.11e-06 | 199 | 145 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 199 | 145 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 199 | 145 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.25e-06 | 200 | 145 | 7 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.25e-06 | 200 | 145 | 7 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.25e-06 | 200 | 145 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.25e-06 | 200 | 145 | 7 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.25e-06 | 200 | 145 | 7 | f9baef67dde62f1c161a9408a78f635ea70ea9d3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.25e-06 | 200 | 145 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.25e-06 | 200 | 145 | 7 | f0818821c495022569aef2c1886d9f2446dc027e | |
| Drug | Vanadates | EXOC6 USP18 MGAM ENPP7 RASA1 TTC28 TNC MYO10 ZNF214 POMT1 HMOX2 USP9Y ADARB1 FBP1 PTPRS UCP2 LRP1 ORAI3 DDX3Y RIPOR1 ADAM17 CPLANE1 CDH6 MRRF | 2.78e-06 | 1302 | 146 | 24 | ctd:D014638 |
| Drug | magnesium | MGAM ENPP7 RHOD GTPBP6 RASA1 DNAH10 TNC PSMA4 ICAM3 GRIA3 FBP2 IDH1 ITGA2B FBP1 PPP3CC FARS2 KCNH2 ADAM17 MMP19 DNAH8 MRRF ILVBL DYNC1H1 EPHA3 | 3.76e-06 | 1325 | 146 | 24 | CID000000888 |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 5.06e-06 | 196 | 146 | 9 | 5111_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 5.49e-06 | 198 | 146 | 9 | 3764_DN | |
| Drug | SA-7 | 7.11e-06 | 42 | 146 | 5 | CID000003300 | |
| Drug | hydroxyl radicals | USP18 MGAM ENPP7 GNE USP11 CLSTN2 FBP2 HMGCS1 IDH1 HMOX2 USP9Y ADARB1 USP16 GDA FBP1 PPP3CC PTPRS SLC18A2 AGL LRP1 CYP4F12 GAPDHS KIR3DL1 | 1.49e-05 | 1341 | 146 | 23 | CID000000961 |
| Drug | citric acid | MGAM FBP2 IDH1 ITGA2B ACSS2 GDI2 PGM3 RNASE4 FBP1 ADAM17 GAPDHS | 2.01e-05 | 357 | 146 | 11 | CID000000311 |
| Drug | 6-chloro-6-deoxymannose | 2.11e-05 | 9 | 146 | 3 | CID000021090 | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.58e-05 | 193 | 146 | 8 | 3348_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 3.58e-05 | 193 | 146 | 8 | 1363_DN | |
| Drug | N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine | 4.08e-05 | 2 | 146 | 2 | ctd:C531033 | |
| Drug | imazapic | 4.08e-05 | 2 | 146 | 2 | CID000091770 | |
| Drug | MDL-29951 | 4.08e-05 | 2 | 146 | 2 | CID005287938 | |
| Drug | dial-AMP | 4.08e-05 | 2 | 146 | 2 | CID005748329 | |
| Drug | imidazole pyruvate | 4.08e-05 | 2 | 146 | 2 | CID000000794 | |
| Disease | epilepsy (implicated_via_orthology) | 1.34e-05 | 163 | 140 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Animal Mammary Neoplasms | 6.18e-05 | 142 | 140 | 6 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 6.18e-05 | 142 | 140 | 6 | C1257925 | |
| Disease | short QT syndrome (implicated_via_orthology) | 6.68e-05 | 3 | 140 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | blood nickel measurement | 2.75e-04 | 120 | 140 | 5 | EFO_0007583 | |
| Disease | Glycogen Storage Disease | 2.81e-04 | 27 | 140 | 3 | C0017919 | |
| Disease | Schizophrenia | SLC25A27 SYN3 MC5R APC GRIA3 ADARB1 KCNH6 FBP1 PPP3CC SLC18A2 KCNH2 UCP2 LRP1 | 3.08e-04 | 883 | 140 | 13 | C0036341 |
| Disease | visceral:subcutaneous adipose tissue ratio | 3.49e-04 | 70 | 140 | 4 | EFO_0004767 | |
| Disease | pentachlorophenol measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 4.10e-04 | 73 | 140 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 4.32e-04 | 74 | 140 | 4 | EFO_0007886 | |
| Disease | Autoinflammatory disorder | 6.12e-04 | 35 | 140 | 3 | C3860213 | |
| Disease | Male sterility due to Y-chromosome deletions | 6.14e-04 | 8 | 140 | 2 | C2931163 | |
| Disease | Partial chromosome Y deletion | 6.14e-04 | 8 | 140 | 2 | C1507149 | |
| Disease | Mammary Neoplasms, Experimental | 8.84e-04 | 155 | 140 | 5 | C0024668 | |
| Disease | long QT syndrome (implicated_via_orthology) | 9.81e-04 | 10 | 140 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Carcinomatosis | 1.11e-03 | 163 | 140 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.11e-03 | 163 | 140 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.11e-03 | 163 | 140 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.11e-03 | 163 | 140 | 5 | C0205696 | |
| Disease | Carcinoma | 1.14e-03 | 164 | 140 | 5 | C0007097 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 1.20e-03 | 11 | 140 | 2 | C0268362 | |
| Disease | glycerophosphorylcholine measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0020018 | |
| Disease | Psychotic Disorders | 1.39e-03 | 101 | 140 | 4 | C0033975 | |
| Disease | blood cobalt measurement | 1.39e-03 | 101 | 140 | 4 | EFO_0007577 | |
| Disease | depressive symptom measurement, stressful life event measurement | 1.74e-03 | 50 | 140 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | Colorectal Carcinoma | 1.96e-03 | 702 | 140 | 10 | C0009402 | |
| Disease | Bipolar Disorder | 2.05e-03 | 477 | 140 | 8 | C0005586 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.57e-03 | 16 | 140 | 2 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.57e-03 | 16 | 140 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.57e-03 | 16 | 140 | 2 | 415000 | |
| Disease | succinylcarnitine measurement | 2.57e-03 | 16 | 140 | 2 | EFO_0020020 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.90e-03 | 17 | 140 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Tourette syndrome, schizophrenia | 3.25e-03 | 18 | 140 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 3.63e-03 | 19 | 140 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | squamous cell carcinoma (is_marker_for) | 3.63e-03 | 19 | 140 | 2 | DOID:1749 (is_marker_for) | |
| Disease | Alzheimer's disease (is_implicated_in) | 3.67e-03 | 132 | 140 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | serum homoarginine measurement | 4.02e-03 | 20 | 140 | 2 | EFO_0005421 | |
| Disease | Nonorganic psychosis | 4.36e-03 | 69 | 140 | 3 | C0349204 | |
| Disease | Osteogenesis imperfecta | 4.42e-03 | 21 | 140 | 2 | cv:C0029434 | |
| Disease | Lung Injury | 4.42e-03 | 21 | 140 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 4.42e-03 | 21 | 140 | 2 | C2350344 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.72e-03 | 71 | 140 | 3 | DOID:0050700 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MESLRGYTHSDIGYR | 1 | Q8N693 | |
| QLHYMVYCRNTGGRY | 161 | O95394 | |
| NAFRYYGTSMHERVN | 71 | Q8N4J0 | |
| DASMARLYGRGLQHY | 276 | Q9UNA0 | |
| LSSMDQEYAGRGYHI | 16 | A2A2Z9 | |
| AEYRGGSYSLRAVQM | 471 | O95841 | |
| TYRNHLLNAARGYME | 971 | Q8N283 | |
| MRTVYGNHERFETTY | 526 | Q9NR19 | |
| IYGVGSMSRYEQVLH | 736 | Q9H4D0 | |
| DYSSVMHYGRLAFSR | 231 | Q6HA08 | |
| LDSMDQEYAGRGYHI | 16 | Q9H560 | |
| RGLRGTHMQHAYDFY | 191 | Q01581 | |
| SYGRVLLAVYRMHSA | 216 | Q8NH16 | |
| VTRSYYRGAAGALMV | 76 | P61106 | |
| YRGAAGALMVYDITR | 81 | P61106 | |
| GYAFVQYMSERHARA | 56 | Q86SE5 | |
| MGGRYYNSIGDIIDH | 411 | P20936 | |
| RGTRTHIYSGTLMDY | 591 | P23458 | |
| MDYLGSRQYVHRDLA | 991 | P23458 | |
| LAYYAAMLGEEHTRS | 341 | Q32P28 | |
| GDNKTQYHMGYFRDS | 121 | Q9NWY4 | |
| THRDSYSGGVVNMYH | 236 | P28062 | |
| TYREFVHRGYLDLMG | 26 | Q9BRQ5 | |
| INGVQTYRLLDYHGM | 241 | Q8N6Y1 | |
| LHMDRNPYYGGESAS | 31 | P50395 | |
| YRGRMSSAALIHHYT | 141 | Q86XE5 | |
| LEAERMTHGYYLASR | 556 | Q4G0Z9 | |
| MTHGYYLASRRIRTG | 561 | Q4G0Z9 | |
| DVAHLYRGVGSRYIM | 236 | O43824 | |
| SVMYLGYAVHRLARA | 91 | Q5T442 | |
| DAIYSARYDGSGHME | 1456 | Q07954 | |
| YHGMNTGYAINPSRD | 216 | A6NL99 | |
| HLSRYEYGTLDNMRE | 381 | O43451 | |
| YLAMNKRGRLYASEH | 96 | P11487 | |
| GNSALRRVMEETYYH | 211 | Q9BVA6 | |
| QRMYGRCSGNEVYHI | 531 | Q5JUK3 | |
| LYSGTARYHTQMLRV | 666 | Q12809 | |
| QRLYSGTARYHTQML | 516 | Q9H252 | |
| RKQYVGAAHGMAGIY | 256 | Q9NS86 | |
| YGARYVGSMVADVHR | 241 | O00757 | |
| RYHANSMGQRSYSFE | 136 | Q6NT76 | |
| SRSSYDMYHLSREGG | 246 | P43629 | |
| RGYHYMLANLGFTDI | 241 | P42263 | |
| RYVLMDGAHGTFRVD | 961 | Q9NYQ8 | |
| GHSRYSQALMAPVYE | 221 | Q99542 | |
| GRHRYGYVCIAMEAL | 66 | Q9Y2G0 | |
| IRMIHGVSRYYNTSE | 266 | Q96JB1 | |
| GGRYDVHLGERMRYA | 86 | O94830 | |
| GLYEPATMEQYSRRH | 111 | Q9HD67 | |
| AHAYTRYMGDLSGGQ | 151 | P30519 | |
| YRAPEILMGSRHYSN | 306 | Q9UBE8 | |
| YHGDHLSRAMYQRIS | 591 | P78563 | |
| YHEHYMRNSRAIGVL | 11 | Q7Z7J7 | |
| QSNMHETVDGYRRYF | 321 | Q8TAG9 | |
| LMYVFREHQRSGSYH | 506 | P32942 | |
| YQVHYVRMEGAEARG | 756 | Q13332 | |
| DVYGHVTLMRSQRNY | 1616 | Q13332 | |
| LVSYNFYTMHRGVGS | 126 | Q86SP6 | |
| DTYPMIYENGRGSSH | 346 | Q9Y6A1 | |
| YGARYVGSMVADVHR | 241 | P09467 | |
| SHNRMKTYDTYVGIG | 186 | O95302 | |
| YDGRHMALYVDGTQV | 371 | Q9BXP8 | |
| VTYHRGQEMARSVGA | 151 | O00212 | |
| GMAYLESRNYIHRDL | 341 | P42685 | |
| RRAGAGDFMRYHYNG | 281 | Q96AY3 | |
| EAAHGTVTRHYRMYQ | 306 | O75874 | |
| AYTDYHKAAMGLGAR | 571 | A1L0T0 | |
| LGSHLIDDYGNTYRM | 46 | Q9Y223 | |
| SEHYSRRISQAYGLM | 2956 | Q9H799 | |
| ASNMARFDGLQYGHR | 336 | Q9H0R6 | |
| TGHDMTRQVSSYYGG | 951 | Q8TF40 | |
| AGMRYLSDLGYVHRD | 746 | P29322 | |
| QHMDFLYYLSHDGRR | 241 | Q9HCS2 | |
| YYLSQRRHRAVMADG | 316 | Q9NQT6 | |
| AMSGGIFAIRRHYFN | 306 | Q7Z4T8 | |
| FTMSYHYRLDGGSLA | 71 | Q9UQ52 | |
| YLSDMGYVHRDLAAR | 736 | P29320 | |
| DGMDRVSFYGAYHSL | 596 | O94769 | |
| YALRYHHIMTARRSG | 146 | P33032 | |
| ASIGRHRYIAYMANQ | 446 | Q8NA54 | |
| SFIRQMVEHGGFYRT | 2681 | Q14204 | |
| VAGGYSYSMLDAIRR | 331 | Q9Y2T3 | |
| TRKNGYNRHEMSTYL | 551 | P55285 | |
| LHMDRNPYYGGESSS | 31 | P31150 | |
| LLMFRYHRRGGYDVE | 181 | Q99075 | |
| NMAYEHHYKGGSRGR | 571 | O15523 | |
| YLGLHGLDNRAYEMT | 756 | P42658 | |
| LMYSDLGYVIHGRIN | 331 | Q6UWV6 | |
| RHTRSYDYMEGGDIR | 51 | P21781 | |
| GYSHRVVDLLRYMFS | 391 | O14556 | |
| FLRYTAGIQRMLDHY | 701 | Q8IVF4 | |
| YMITSLDRTHAGFYR | 76 | Q58EX2 | |
| GRLYQVEYAMEAIGH | 16 | P25789 | |
| YMNRAYHAILQGRLG | 896 | Q5VW36 | |
| GRDLSYCLSGMYDHR | 261 | P52597 | |
| QHAYSMALGEDYRSL | 166 | O14994 | |
| YEYRVLMSTLHGGTN | 2696 | O75445 | |
| GIYRSNMDGSAAYHL | 901 | Q92673 | |
| HRKQYGGDFLRARMY | 141 | Q96DL1 | |
| MRGTRCLAEYHLGDY | 246 | Q5VZ19 | |
| AGSHREAGMRAIYNV | 701 | Q9BQS7 | |
| MRALAGTYRCYGSVT | 186 | Q14943 | |
| SRSSYDMYHLSREGG | 246 | Q14943 | |
| LMLTGRFSHRIYVAY | 226 | P46977 | |
| ERQHGHRQYMAYSAV | 36 | Q96E11 | |
| GYQTDMHSVSRHGYQ | 86 | Q9UKZ4 | |
| RHSLQTMLSVGYYRN | 1921 | Q9UKZ4 | |
| YMRRDGKGQVYNNLH | 176 | Q9BVH7 | |
| LRGEQMASYFGHSVA | 311 | P08514 | |
| YRSSMRELVGSGRYD | 951 | Q6P1J6 | |
| EANYHLYGSRMDRQT | 381 | Q13546 | |
| SRSGTHNMYREYRDL | 86 | Q02543 | |
| HNMYREYRDLTTAGA | 91 | Q02543 | |
| RHNYRKAGTVMFEYG | 1091 | Q12769 | |
| HNGNPRYTRVTAMEY | 1061 | Q8N122 | |
| MLDNLGYRTGYTYRH | 371 | P35612 | |
| ADHRFYRYMGRGEES | 231 | P78536 | |
| DHYSITLRRYAGMAL | 491 | P25054 | |
| SRSHGTDLYRGEKMY | 421 | Q86X95 | |
| MESEQLFHRGYYRNS | 1 | P51790 | |
| QQGMTAYGTRRHLYD | 176 | P51911 | |
| QAGMTAYGTRRHLYD | 176 | Q15417 | |
| AHEAQDAGYRMYRKS | 276 | P48454 | |
| SYGQDGMYQRFLRQH | 26 | P34096 | |
| YTQGRGSHSQEMRYN | 731 | Q8N2E2 | |
| RYMNSALGQYSSAGH | 241 | P55851 | |
| GQAFVMGSYLAEHRR | 336 | Q6ZNH5 | |
| TRETYGSGTQYHMQL | 231 | Q86VN1 | |
| LYSLYGVVEHSGTMR | 741 | Q9Y5T5 | |
| LYRDVMRETYGHLGA | 61 | Q9BV97 | |
| NRGRIGVVIAAYMHY | 116 | Q9HBL0 | |
| YRNCHRVNLMGRYGD | 2146 | P24821 | |
| YRHVVYSGGRMVTYE | 96 | O95847 | |
| YSGGRMVTYEHLREV | 101 | O95847 | |
| MTHLSNYGNDRLGLY | 526 | P52849 | |
| MDPRGRSHLSGYDYV | 2396 | P02549 | |
| LATYMNSIRLYAGDH | 621 | O00507 | |
| YRDVMQETYGHLGAL | 51 | P0C7X2 | |
| GGMSQEAHANLYSRY | 416 | O15090 | |
| SSLMGYQYHQRRCGK | 606 | Q96KM6 | |
| GSAYHYRRNFDKAMS | 401 | Q96AY4 | |
| IYYHVVETGSMGARL | 216 | Q99805 | |
| VGMADSGHYCVYIRN | 311 | Q3LFD5 | |
| VGMADSGHYCVYIRN | 311 | Q9UMW8 | |
| MSRRRRYEGHKVEGY | 461 | Q64LD2 | |
| MVGSALRRGAHAYVY | 1 | O95363 | |
| GDNYYLNRTHMLRAH | 141 | O95363 | |
| MGYLVDLRHVSVYGS | 406 | Q05940 | |
| LRDGAYNMVRAYTTG | 156 | Q6ZS17 | |
| GTHCSRNAYMLVYRL | 406 | Q86UV5 | |
| KYDLIAVSNHYGGMR | 871 | P51784 | |
| TTQDYGREIYMSGSH | 146 | Q9UL59 | |
| DGSMAYIHRTPREGY | 66 | P36508 | |
| YRDVMRETYGHLSAL | 51 | Q96H86 | |
| MSAYNSHEEGRLVYR | 581 | P35573 | |
| HMPYGYAAQARARER | 16 | P22459 |